Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 1 | 1 | 1 | 3 | 2 |
| Gross Profit | 1 | 1 | 1 | 3 | 2 |
| Operating Expenses | 6,606 | 7,792 | 8,526 | 7,449 | 7,553 |
| Operating Income | -6,605 | -7,791 | -8,525 | -7,446 | -7,551 |
| Pre-tax Income | -6,605 | -7,791 | -8,525 | -7,446 | -7,551 |
| Net Income Continuous | -6,605 | -7,791 | -8,525 | -7,446 | -7,551 |
| Net Income | $-6,605 | $-7,791 | $-8,525 | $-7,446 | $-7,551 |
| EPS Basic Total Ops | -0.27 | -0.32 | -0.35 | -0.31 | -0.32 |
| EPS Basic Continuous Ops | -0.27 | -0.32 | -0.35 | -0.30 | -0.32 |
| EPS Diluted Total Ops | -0.27 | -0.32 | -0.35 | -0.31 | -0.32 |
| EPS Diluted Continuous Ops | -0.27 | -0.32 | -0.35 | -0.30 | -0.32 |
| EBITDA(a) | $-6,601 | $-7,784 | $-8,515 | $-7,436 | $-7,541 |